Revised guideline on clinical studies for Alzheimer's disease medicines

View source ↗

Summary

EU EMA releases a revised guideline outlining expectations for clinical studies assessing Alzheimer's disease medicines, including design, endpoints, and regula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease